Pfizer to Invest More Than $2.5 Billion to Expand European Manufacturing
Pfizer is investing more than $2.5 billion at its drug making plants in Belgium and Ireland, gearing up to launch new products it hopes can replace lost revenue as patents expire and COVID-19 vaccine sales decline.
Reuters Health Information
source https://www.medscape.com/viewarticle/984908?src=rss
Reuters Health Information
source https://www.medscape.com/viewarticle/984908?src=rss
Comments
Post a Comment